Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Thorax. 2022 Jan 7;77(5):508–510. doi: 10.1136/thoraxjnl-2021-217693

Table 2.

Clinical characteristics of HP

Fibrotic HP (%) Non-fibrotic HP (%) P value
Subjects 152 47
Sex (male/female) 66 (43)/86(57) 16(34)/31(66) 0.25
Age 62.0±10.1 59.4±9.6 0.09
Smoking History (ever/never) 86 (57)/64(42) 21(45)/26(55) 0.13
Antigen identification (yes/no/unknown) 97 (63)/40 (26)/15(10) 22(47)/9 (19)/16(34) 0.99
Pulmonary function
 %FVC 62.6±21.7 76.8±16.7 0.0005
 %Dlco 50.3±20.4 61.0+18.8 0.008

%DLco, diffusing capacity of the lung for carbon monoxide, % of predicted value; %FVC, forced vital capacity, % of predicted value; HP, hypersensitivity pneumonitis.